Skip to main content
Clinical Trials/CTRI/2022/11/047070
CTRI/2022/11/047070Not yet recruitingPhase 3

EFFICACY OF INJECTABLE PLATELET RICH FIBRIN ON ACCELERATING MOLAR DISTALISATION DURING EN MASSE RETRACTION USING IZC -A RANDOMISED CONTROL TRIA

Saveetha Dental College and Hospitals0 sites0 target enrollmentStarted: TBDLast updated:

Trial Snapshot

Phase
Phase 3
Status
Not yet recruiting

Study Overview

Brief Summary

No summary available.

Study Design

Study Type
Interventional

Eligibility Criteria

Inclusion Criteria

  • 1.PATIENTS REQUIRING IZC AIDED EN MASSE RETRACTION WITH EXTRACTION OF 8â??s
  • 2.AGED -18-35 YEARS
  • 3.NO SYSTEMIC ILLNESS, ABSENCE OF BONE METABOLIC DISORDERS.
  • 4.PERIODONTALLY HEALTHY SUBJECTS.
  • 5.GOOD ORAL HYGIENE.
  • 6.PATIENTS WITHIN THE ACCEPTABLE UNIFORM RANGE OF BONE DENSITY.

Exclusion Criteria

  • 1. PATIENTS WITH SYSTEMIC ILLNESS, BONE METABOLIC DISORDERS.
  • 1.PERIODONTALLY COMPROMISED SUBJECTS.

Investigators

Similar Trials